Loading term…
The percentage of regulatory submissions completed within required timeframes, a key indicator of pharmacovigilance operational performance.
Of 100 expedited reports due this quarter, 98 were submitted on time, yielding a 98% compliance rate. The 2 late submissions are investigated for root cause.
EU GVP Module I, FDA Compliance
Celebrating high compliance rates without investigating the late submissions, which may indicate systemic issues.
What is your expedited reporting compliance rate? How do you investigate and address late submissions?